SENSEX NIFTY

Glaxosmithkline Pharmaceuticals Ltd

Feb 24, 2015 at 18:02 | Source: Moneycontrol.com
Lyka Labs has board meeting held on February 24, 2015, has allotted 230000 Warrants of Rs. 28/- each to N. I. Gandhi (HUF) and Enai Trading and Investment Pvt. Ltd of Promoter Group aggregating 460000 Warrants under Series - I on Preferential basis with a conversion into Equity within a period of 18 months from the date of Allotment.
Feb 24, 2015 at 15:53 | Source: Reuters
The projects are in Mumbai, Delhi, Bangalore, Pune and Chennai, Piramal Fund Management said. The company will eventually expand financing to smaller cities such as Jaipur, Ahmedabad, Nagpur and Hyderabad, Jijina said.
Feb 20, 2015 at 12:28 | Source: Moneycontrol.com
Beryl Drugs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 20, 2015, has considered and approved delisting of securities from M.P. Stock Exchange.
Feb 18, 2015 at 13:54 | Source: Moneycontrol.com
Shares of Lupin gained 1.6 percent intraday Wednesday on signing joint venture agreement with Poland-based Celon Pharma for generic asthma drug.
Feb 17, 2015 at 15:35 | Source: PTI
Lupin and Celon Pharma SA have entered into a definitive agreement under which the companies will jointly develop fluticasone/salmeterol dry powder inhaler (DPI) product which is a generic version of GlaxoSmithKline's Advair Diskus, the Mumbai-based firm said in a statement.
Feb 16, 2015 at 15:51 | Source: Moneycontrol.com
Arvind Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 11, 2015, has decided that in the next Board Meeting convened on February 27, 2015, the Corporate Restructuring proposal with Bankers be taken for discussion.
Feb 16, 2015 at 13:25 | Source: Moneycontrol.com
Toheal Pharmachem Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 12, 2015, has considered and approved notice sent to Equity Shareholders whose share are partly paid up for Forfeiture of 30,89,500 partly paid up Equity Shares.
Feb 15, 2015 at 14:30 | Source: PTI
It had posted a net profit of Rs 47.60 crore for the October-December quarter of 2013-14 fiscal, Pfizer Ltd said in a filing to the BSE. Net sales during the quarter under review were Rs 464.56 crore.
Feb 13, 2015 at 17:52 | Source: PTI
"The JV company will manufacture and market respiratory products facilitating Cipla's front-end presence in Algeria," it added. As per the agreement, Cipla's wholly owned subsidiary, Cipla (EU) Ltd, will hold a 40 percent stake in the JV company while the remainder will be held by a Biopharm-led Algerian consortium.
Feb 13, 2015 at 15:03 | Source: Moneycontrol.com
Beryl Drugs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 20, 2015, to consider and approve the delisting of securities from M.P. Stock Exchange.
Messages on Glaxosmithkline Pharmaceuticals Ltd »

BSE/NSE Announcer

Platinum Member

6670 Followers

GlaxoSmithKline  

12.06 PM May 16th 2014

BSE/NSE Announcer

Platinum Member

6670 Followers

GlaxoSmithKline  

12.18 PM Apr 17th 2014

BSE/NSE Announcer

Platinum Member

6670 Followers

GlaxoSmithKline  

3.55 PM Mar 26th 2014

BSE/NSE Announcer

Platinum Member

6670 Followers

GlaxoSmithKline  

2.00 PM Mar 25th 2014

BSE/NSE Announcer

Platinum Member

6670 Followers

GlaxoSmithKline  

4.39 PM Mar 13th 2014

vk1939

Platinum Member

167 Followers

GlaxoSmithKline  

7.08 PM Feb 18th 2014

yrfriend007

Platinum Member

110 Followers

GlaxoSmithKline  

3.51 PM Feb 18th 2014

BSE/NSE Announcer

Platinum Member

6670 Followers

GlaxoSmithKline  

2.00 PM Feb 18th 2014

BSE/NSE Announcer

Platinum Member

6670 Followers

GlaxoSmithKline  

1.51 PM Feb 18th 2014

kabiroberoi
90

New Member

0 Follower

GlaxoSmithKline  

1.04 PM Feb 18th 2014

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.